Startup Valuation Methods: Deal Heuristics vs. Fair Value Reporting

"How do you value a pre-revenue startup" is two questions with two audiences.

• Pricing a deal. An angel investor or early-stage VC needs a negotiating anchor before any money changes hands. No revenue, sometimes no product, so the tools are qualitative heuristics dressed up with figures.
• Reporting fair value. A fund that has already invested has to report what the stake is worth at each subsequent reporting date, for its own financial statements. A formal, standard-governed exercise, not a negotiation.

Most explainers list both sets of methods together as though they answered the same question.

• Berkus. Assigns a value, up to roughly half a million each, to five qualitative factors: sound idea, working prototype, quality of management team, strategic relationships, and early sales rollout. Pre-money value tops out by design.
• Scorecard. Starts from the average pre-money valuation of recently funded startups in the same region and sector, then adjusts using a weighted scorecard across team, market size and competition.
• Risk Factor Summation. Same starting point, adjusted against roughly twelve named risk categories instead of a scorecard.

These do what they were built for: give two people in a negotiation a number to start from when there is no financial history. None is a recognised valuation standard, and none would certify a number for a statutory filing or audited accounts. The reasons are specific rather than a matter of taste, covered in Are Berkus and Scorecard Acceptable to a Professional Valuer?.

Funds valuing portfolio companies for their own financial statements work from theInternational Private Equity and Venture Capital Valuation Guidelines, which sit alongside the International Valuation Standards covered in What Valuation Standard Actually Governs an SFA Registered Valuer?. IVS governs the conduct of valuation work generally; IPEV addresses how private capital practitioners apply the fair value objective to their portfolios. The named methods, from the current IPEV text:

• Calibration (Guideline 2.6). The dominant technique in practice. If the most recent round was arm's length, its price is fair value at that date. The valuer works backward to find the multiple or discount rate that price implies against comparables, then rolls that calibrated figure forward as the comparables move.
• Scenario-based methods, including the probability-weighted expected return method. Multiple future outcomes modelled, each assigned a value and a probability, weighted together.
• The option pricing method. Treats each class of equity as a call option on total enterprise value, useful when outcomes form a continuous range. This is the allocation problem a multi-class cap table creates, the same complexity that makes pricing a CCPS conversion more involved than pricing plain equity.
• The hybrid method, a blend of scenario-based methods and OPM.
• The current value method. Used when an exit is imminent, allocating value across equity classes as though the company were sold on the measurement date.

IPEV's own illustration makes the mechanic concrete. A fund invests at a price implying 8x EBITDA. Comparable companies are trading at 10x at the time. That gap, a 20% discount to the comparables, is not an error. It is calibrated in, capturing everything about this specific company — illiquidity, control, growth rate — that justifies trading below the peer set.

At the next reporting date the valuer does not start over. If the comparable set has moved from 10x to 15x, judgement is applied to how much of that move the portfolio company should track, informed by the calibrated 20% discount rather than by rebuilding a fresh multiple.

IPEV is explicit that no single method is superior in all circumstances, but it gives a practical steer. Early in a company's life, when the exit route is unclear, more weight tends to go to the hybrid or OPM approach, since those account for the different rights and preferences each investor class holds.

As a company nears an actual exit through an IPO or acquisition, where everyone is likely to receive close to the same price per share, weight shifts to a fully-diluted, common-stock-equivalent view.

Establish which of the two exercises you are being asked for before choosing a method, because the wrong one is not merely imprecise, it is inadmissible. A negotiating anchor in a statutory filing has no standard behind it; a calibrated fair value in a term sheet negotiation answers a question nobody asked.

None of this displaces DCF for statutory work under Section 62(1)(c). DCF answers what the underlying business is worth from its own projected cash flows. Calibration, PWERM, OPM, the hybrid method and CVM answer a question layered on top: given that value, or given a real transaction price nobody wants to discard, how should it be allocated across a cap table with multiple classes of rights, or rolled forward without a full exercise every quarter.

The same allocation logic applies when classes differ in voting power rather than liquidation preference, covered in DVR Shares Are a Valuer's Job. The Standards Go Quiet on the Number.